What is the acute management for a patient with severe hyponatraemia (serum sodium 118 mmol/L) in the setting of tuberculous meningitis and possible intracranial hypertension?

Acute Management of Severe Hyponatremia (Na 118) in Tuberculous Meningitis

In a patient with tuberculous meningitis and serum sodium of 118 mmol/L, you must first determine if this is cerebral salt wasting (CSW) versus SIADH by assessing volume status, then treat with hypertonic saline (3% NaCl) targeting an initial correction of 5-6 mmol/L over 6 hours, with total correction not exceeding 8 mmol/L in 24 hours. 1

Immediate Assessment Priority

Determine the underlying mechanism:

• CSW (more common in TBM): Evidence of hypovolemia—dehydration, polyuria, negative fluid balance, weight loss, hypotension, poor peripheral perfusion, high urinary sodium (>40 mmol/L), elevated fractional excretion of uric acid 1, 2, 3
• SIADH: Euvolemia or hypervolemia, normal to low urine output 1

This distinction is critical because treatment of one may be detrimental to the other—CSW requires aggressive volume and salt replacement while SIADH traditionally involves fluid restriction (though fluid restriction has not been beneficial in TBM and should be avoided) 1.

Acute Treatment Protocol

For Severe Symptomatic Hyponatremia (Na <120 with altered mental status/seizures):

Hypertonic Saline (3% NaCl):

• Calculate sodium deficit: Desired increase in Na (mmol/L) × (0.5 × ideal body weight in kg) 4
• Target correction: 5-6 mmol/L over first 6 hours OR until severe symptoms (seizures, coma) resolve 4, 5
• Critical limit: Do NOT exceed 8 mmol/L correction in first 24 hours 4, 1, 5
• Subsequent days: Maximum 8-10 mmol/L per 24-hour period 5, 6

Rationale for limited correction: While severe hyponatremia causes cerebral edema requiring urgent treatment, overcorrection risks osmotic demyelination syndrome (central pontine myelinolysis), which has increased risk in advanced disease 7, 5, 6.

Volume Management Based on Mechanism:

If CSW (hypovolemic):

• Aggressive saline replacement (0.9% or 3% NaCl depending on severity) 1, 2, 3
• Oral salt supplementation (NaCl 100 mEq PO TID) 4
• Fludrocortisone 0.1-0.2 mg daily for refractory cases—helps normalize sodium without affecting polyuria 1, 2, 3
• Monitor for volume contraction which may contribute to border zone infarctions in TBM 1

If SIADH:

• Avoid fluid restriction in TBM—has not been beneficial 1
• Consider V2 receptor antagonists (conivaptan or tolvaptan) if refractory 7, 1

Monitoring Requirements

Frequent sodium checks:

• Q2 hours during acute correction phase 4
• Q4 hours once stabilized 4
• Monitor urine output continuously—polyuria may indicate CSW or unwanted water diuresis 1, 5

Watch for overcorrection:

• If inadvertent overcorrection occurs, administer desmopressin to terminate water diuresis 5
• May also use intravenous dextrose to reverse overcorrection 6

Concurrent Management of Intracranial Hypertension

Basic measures to control ICP (per meningitis guidelines) 8:

• Maintain euvolemia—fluid restriction NOT recommended even with cerebral edema 8
• Target MAP ≥65 mmHg (may need 70 mmHg with cerebral edema to maintain cerebral perfusion pressure) 8
• Head elevation
• Avoid hyperthermia and maintain normoglycemia 8
• Maintain normocarbia 8
• Crystalloids are initial fluid of choice when IV therapy required 8

Critical care consultation should be obtained early given risk of rapid deterioration 8.

Common Pitfalls to Avoid

1. Do not restrict fluids aggressively in TBM with hyponatremia—this contradicts traditional SIADH management but is specific to TBM 1
2. Do not correct sodium too rapidly—the 8 mmol/L/24-hour limit is absolute to prevent osmotic demyelination 4, 1, 5
3. Do not assume SIADH—CSW is actually more common in TBM and requires opposite treatment 1
4. Do not use glycerol—contraindicated in bacterial meningitis with increased mortality in adults 8, 9
5. Monitor for persistent hyponatremia and increasing urinary output during treatment—these strongly predict death and neurological events 10, 11

Prognostic Considerations

Severe hyponatremia (<120 mmol/L) in TBM associates with more severe disease, lower Glasgow Coma Scale, and increased CSF inflammation 10, 11. While hyponatremia reflects disease severity, aggressive correction beyond safe limits does not independently improve mortality 11, reinforcing the importance of measured, controlled correction to avoid iatrogenic harm.